Provided by Tiger Fintech (Singapore) Pte. Ltd.

Salarius Pharmaceuticals Inc

4.56
-0.9950-17.91%
Post-market: 4.50-0.0600-1.32%19:59 EDT
Volume:1.38M
Turnover:7.22M
Market Cap:2.32M
PE:-0.07
High:4.70
Open:4.40
Low:4.23
Close:5.56
52wk High:108.00
52wk Low:4.23
Shares:509.64K
Float Shares:509.00K
Volume Ratio:1.85
T/O Rate:270.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-66.9952
EPS(LYR):-86.9214
ROE:-660.37%
ROA:-143.52%
PB:-2.80
PE(LYR):-0.05

Loading ...

Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 17, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Correspondence

Form CORRESP - Correspondence
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report